Intraday Calls 28th May 2009
+ve Sector & Scripts : CNX nifty junior, CNX100, Metal, Bank, IT,
Wipro, Bhartforge, Canbank
+ve Sector & Scripts : CNX nifty junior, CNX100, Metal, Bank, IT,
Wipro, Bhartforge, Canbank
BUY Cairn-219 above 221 for a target 226 stop loss 219
BUY STER-591 above 595 for a target 605 stop loss 592
BUY Auropharma-384 above 388 for a target 395 stop loss 384
BUY STER-591 above 595 for a target 605 stop loss 592
BUY Auropharma-384 above 388 for a target 395 stop loss 384
Expected Breakout Calls
BUY AXISBank-797 above 800 for a target 890 stop loss 770
BUY BHEL-2082 above 2115 for a target 2150 stop loss 2100
BUY MTNL-105 above 107 for a target 113 stop loss 105
BUY AXISBank-797 above 800 for a target 890 stop loss 770
BUY BHEL-2082 above 2115 for a target 2150 stop loss 2100
BUY MTNL-105 above 107 for a target 113 stop loss 105
Breakout Calls
BUY HCL-Tech-174 for a target 181 stop loss 171
BUY IDFC-126 for a target 136 stop loss 123
BUY L&T-1312 for a target 1380 stop loss 1280
BUY HCL-Tech-174 for a target 181 stop loss 171
BUY IDFC-126 for a target 136 stop loss 123
BUY L&T-1312 for a target 1380 stop loss 1280
Strong & Weak futures
This is list of 10 strong futures:
This is list of 10 strong futures:
Parsvnath, Alok Text, Ansal infra, Redington, Gitanjali, NIIT, JP Hydro, Patel Eng, Finan Tech & HCC.
And this is list of 10 Weak :
Cipla, ITC, Bharti Airtel, Colpal, Hind Uni Lvr, Sterlin Bio,Glaxo, NTPC, Tata Tea & TCS.
Nifty is in Up Trend .
Nifty is in Up Trend .
NIFTY FUTURES (F & O):
Below 4256 level, expect profit booking up to 4212-4214 zone and thereafter slide may continue up to 4169-4171 zone by non-stop.
Below 4256 level, expect profit booking up to 4212-4214 zone and thereafter slide may continue up to 4169-4171 zone by non-stop.
Hurdle at 4294 level. Above this level, buying may continue up to 4304 level by non-stop.
Cross above 4346-4348 zone, can take it up to 4389-4391 zone. Supply expected at around this zone and have caution.
On Negative Side, rebound expected at around 4042-4044 zone. Stop Loss at 4000-4002 zone.
Short-Term Investors:
Bearish Trend. 3 closes below 4620 level, it can tumble up to 3790 level by non-stop.
BSE SENSEX:
Lower opening expected. Recovery should continue.
Lower opening expected. Recovery should continue.
Short-Term Investors:
Short-Term trend is Bearish and target at around 12478 level on down side.
Maintain a Stop Loss at 14931 level for your short positions too.
POSITIONAL BUY:
Sell BHARTI AIRTEL (NSE Cash)
Lower opening expected. Selling may continue.
If trades below 788 level, then selling may continue up to 750 level. Break below 727 level, expect free fall too.
If crosses 788 level, then traders can expect short covering up to 812 level.
Sell HIND UNILEVER (NSE Cash)
Lower opening expected. Selling may continue.
If trades below 236 level, then selling may continue up to 224 level. Break below 218 level, expect free fall too.
If crosses 236 level, then traders can expect short covering up to 243 level.
Sell BAJAJ HINDUSTAN (NSE Cash)
Lower opening expected. Selling may continue.
If trades below 139 level, then selling may continue up to 133 level. Break below 129 level, expect free fall too.
If crosses 139 level, then traders can expect short covering up to 144 level.
Sell BALRAMPUR CHINI MILLS FUTURES (NSE)
Lower opening expected. Selling may continue.
If trades below 85 level, then selling may continue up to 81 level. Break below 78 level, expect free fall too.
If crosses 85 level, then traders can expect short covering up to 88 level.
Sell SHREE RENUKA SUGARS FUTURES (NSE)
Lower opening expected. Selling may continue.
If trades below 126 level, then selling may continue up to 120 level. Break below 116 level, expect free fall too.
If crosses 126 level, then traders can expect short covering up to 130 level.
Global Cues & Rupee
The Dow Jones Industrial Average closed at 8,300.02. Down by 173.47 points.
The Broader S&P 500 closed at 893.06. Down by 17.27 points.
The Dow Jones Industrial Average closed at 8,300.02. Down by 173.47 points.
The Broader S&P 500 closed at 893.06. Down by 17.27 points.
The Nasdaq Composite Index closed at 1,747.62. Down by 19.35 points.
The partially convertible rupee <INR=IN> ended at 47.70/71 per dollar on yesterday, stronger than it's previous close of 47.88/90.
SPOT LEVELS TODAY
 | 4276.05 | ( 3.87 %) | 159.35 |  |
| 1 | 2 | 3 | ||
| Resistance | 4336.58 | 4397.12 | 4507.78 | |
| Support | 4165.38 | 4054.72 | 3994.18 | |
 | 14109.64 | ( 3.83 %) | 520.41 | | |
| 1 | 2 | 3 | |||
| Resistance | 14228.14 | 14346.65 | 14570.51 | ||
| Support | 13885.77 | 13661.91 | 13543.40 | ||
FII DATA
| FII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores) | ||||
| Category | Date | Buy Value | Sell Value | Net Value |
| FII | 27-May-2009 | 3957.85 | 3588.05 | 369.8 |
| DII trading activity on NSE and BSE in Capital Market Segment(In Rs. Crores) | ||||
| Category | Date | Buy Value | Sell Value | Net Value |
| DII | 27-May-2009 | 2190.65 | 1505.01 | 685.64 |
DELIVERY
Venus Remedies-Value Buy
FY10 EPS forecast at Rs 55 and FY11 EPS forecast at Rs 62, at 4 times FY10 earnings this is the cheapest innovator drug company in India.
Venus Remedies-Value Buy
FY10 EPS forecast at Rs 55 and FY11 EPS forecast at Rs 62, at 4 times FY10 earnings this is the cheapest innovator drug company in India.
Venus Remedies Ltd has been granted permission to conduct Phase III clinical trials on a novel Injectable aminoglycoside by the Controller General Of India. The molecule was in-licensed from Chinese Innovator Company by Venus who has the exclusive marketing rights for this product in India. The molecule is a latest generation aminoglycoside in injectable form.
The drug is indicated for Lower Respiratory Tract infections like bronchitis, COPD, pneumonia, Skin and skin structure infections, Sexually Transmitted Diseases, Urinary tract infections, Digestive tract infections and Surgical infections caused by various pathogens. Intellectual property rights for this product have already been protected. Innovator Company in China has the worldwide patent for this product.
(Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.)
--
Arvind Parekh
+ 91 98432 32381
